首页> 外文期刊>Annals of clinical biochemistry. >The development of a system for the reporting, classification and grading of quality failures in the clinical biochemistry laboratory
【24h】

The development of a system for the reporting, classification and grading of quality failures in the clinical biochemistry laboratory

机译:临床生化实验室中质量缺陷报告,分类和分级系统的开发

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: There is no agreed system for the reporting, classification and grading of the severity of quality failures in the clinical biochemistry laboratory.Methods: A 'Quality Query' reporting system was set up to log all quality failures identified by staff and service users. Quality failures were classified into three major groups of the preanalytical, analytical and postanalytical phases with appropriate subcategories in each group. The severity of each quality failure was graded using a five-point scoring system incorporating both actual ('A') and potential ('P') score elements. The 'A' score measured the actual adverse impact of the quality failure on patient care, while the 'P' score measured the 'worst case' potential outcome that might have resulted. The system was assessed over a 19-month period.Results: Three hundred and ninety-seven Quality Query reports were completed (0.085% of all requests). Breakdown by cause: pre-analytical phase - 88.9%, analytical phase - 9.6%, post-analytical phase - 1.5%. The quality failure severity 'A' scores were skewed towards a low adverse impact on patient care: 72.7% allocated an 'A' score of 1 (least severe grade). The 'P' scores were skewed towards a high potential impact on patient care: 65.9% allocated a 'P' score of 5 (most severe grade). Conclusions: The Quality Query reporting system proved easy to integrate into routine laboratory practice. Although the great majority of quality failures had minimal adverse impact on patient care, the potential for adverse outcomes was much higher. This system generates important information on laboratory performance and helps inform risk management priorities.
机译:背景:临床生物化学实验室中没有质量缺陷严重程度的报告,分类和分级的共识系统。方法:建立了“质量查询”报告系统,以记录员工和服务用户发现的所有质量缺陷。质量失败分为分析前,分析和分析后阶段的三个主要组,每组中都有适当的子类别。使用结合了实际('A')和潜在('P')评分元素的五点评分系统对每个质量失败的严重程度进行评分。 “ A”等级衡量的是质量缺陷对患者护理的实际不利影响,而“ P”等级衡量的是可能导致的“最坏情况”的潜在后果。在19个月的时间内对系统进行了评估。结果:完成了377个质量查询报告(占所有请求的0.085%)。按原因细分:分析前阶段-88.9%,分析阶段-9.6%,分析后阶段-1.5%。质量失败严重程度'A'评分偏向对患者护理的不良影响较低:72.7%的'A'评分为1(最低严重等级)。 “ P”评分偏向对患者护理具有较高的潜在影响:65.9%的“ P”评分为5(最严重)。结论:质量查询报告系统被证明易于集成到常规实验室实践中。尽管绝大多数质量失败对患者护理的不良影响极小,但产生不良后果的可能性却更高。该系统生成有关实验室性能的重要信息,并有助于告知风险管理优先级。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号